V3 serotyping of HIV-1 infection: Correlation with genotyping and limitations

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 5, 1999, Pages 432-441

  Plantier, Jean Christophe ^a   Damond, Florence ^b   Lasky, Mariama ^c   Sankalé, Jean Louis ^d   Apetrei, Christian ^b,e   Peeters, Martine ^c   Buzelay, Laurence ^a   M'Boup, Souleymane ^f   Kanki, Phyllis ^d   Delaporte, Eric ^c   Simon, François ^b   Barin, Francis ^a,g  

^a UNIVERSITÉ DE TOURS   (France)

^b BICHAT HOSPITAL   (France)

^c Inst Francais de Rech Sci P   (France)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^f UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^g CHU BRETONNEAU   (France)

Author keywords

Genotyping; HIV 1; V3 serotyping

Indexed keywords

SYNTHETIC PEPTIDE;

ARTICLE; ENZYME IMMUNOASSAY; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SEROTYPE; VIRUS INFECTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

AMINO ACID SEQUENCE; FEMALE; GENOTYPE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; SEROTYPING;

EID: 0033560726     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199904150-00004     Document Type: Article

References (56)

1. Loussert-Ajaka I, Chaix ML, Korber B, et al. Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol 1995;69:5640-9.
2. Gould K, Britvan L, Dryjanski J. HIV-1 group O infection in the USA. Lancet 1996;348:680-1.
3. Soriano V, Gutierrez M, Garcia-Lerma G, et al. First case of group O infection in Spain. Vox Sang 1996;71:66.
4. Myers G, Korber B, Wain-Hobson S, Smith RF, Pavlakis GN. Human retroviruses and AIDS 1992: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos, NM: Los Alamos National Laboratory: Theoretical Biology and Biophysics, 1992.
5. Myers G, Korber B, Wain-Hobson S, Smith RF, Pavlakis GN. Human retroviruses and AIDS 1994: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos, NM: Los Alamos National Laboratory: Theoretical Biology and Biophysics, 1994.
6. Myers G, Korber B, Wain-Hobson S, Smith RF, Pavlakis GN. Human retroviruses and AIDS 1995: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos, NM: Los Alamos National Laboratory: Theoretical Biology and Biophysics, 1995.
7. Expert Group of the Joint United Nations Programme on HIV/ AIDS. Implications of HIV variability for transmission: scientific and policy issues. AIDS 1997;11:1-15.
8. Ariyoshi K, Cheingsong-Popov R, Wilkins A, Corrah T, Weber J, Whittle H. HIV-1 subtype B in West Africa. Lancet 1996;347:328.
9. Janssens W, Heyndrickx L, Fransen K, et al. Genetic and phylogenetic analysis of env subtypes G and H in Central Africa. AIDS Res Hum Retroviruses 1994;10:877-9.
10. Murphy EE, Korber B, Georges-Courbot MC, et al. Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the Central African Republic. AIDS Res Hum Retroviruses 1993;9:997-1006.
11. Nkengasong JN, Janssens W, Heyndrickx L, et al. Genotypic subtypes of HIV-1 in Cameroon. AIDS 1994;8:1405-12.
12. Brodine SK, Mascola JR, Weiss PJ, et al. Detection of diverse HIV-1 genetic subtypes in the USA. Lancet 1995;346:1198-9.
13. Gao F, Yue L, Hill SC, et al. HIV-1 sequence subtype D in the United States. AIDS Res Hum Retroviruses 1994;10:625-7.
14. Montpetit M. HIV-1 subtype A in Canada. AIDS Res Hum Retroviruses 1995;11:1421-2.
15. Artenstein AW, Coppola J, Brown AE, et al. Multiple introductions of HIV-1 subtype E into the western hemisphere. Lancet 1995;346:1197-8.
16. Bandea CI, Ramos A, Pieniazek D, et al. Epidemiologic and evolutionary relationships between Romanian and Brazilian HIV-1 subtype F strains. Emerg Infect Dis 1995;1:91-3.
17. Csillag C. HIV-1 subtype C in Brazil. Lancet 1994;344:1354.
18. Clewley JP, Arnold C, Barlow KL, Grant PR, Parry JV. Diverse HIV-1 genetic subtypes in UK. Lancet 1996;347:1487.
19. Fransen K, Buvé A, Nkengasong JN, Laga M, van der Groen G. Longstanding presence in Belgians of multiple non-B HIV-1 subtypes. Lancet 1996;347:1403.
20. Simon F, Loussert-Ajaka I, Damond F, Saragosti S, Barin F, Brun-Vézinet F. HIV-1 diversity in Northern Paris, France. AIDS Res Hum Retroviruses 1996;12:1427-33.
21. Op de Coul E, Lukashov VV, van Doornum GJJ, Goudsmit J, Coutinho RA. Multiple HIV-1 subtypes present amongst heterosexuals in Amsterdam 1988-1996: no evidence for spread of non-B subtypes. AIDS 1998;12:1253-5.
22. Bobkov A, Cheingsong-Popov R, Garaev M, et al. Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russia Federation and Belarus. AIDS 1994;8:1649-55.
23. Bobkov A, Cheingsong-Popov R, Selimova L, et al. Genetic heterogeneity of HIV type 1 in Russia: identification of H variants and relationship with epidemiological data. AIDS Res Hum Retroviruses 1996;12:1687-90.
24. Lukashov VV, Karamov EV, Eremin VF, Titov LP, Goudsmit J. Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, Belarus. AIDS Res Hum Retroviruses 1998;14:1299-303.
25. Liitsola K, Tashkinova I, Laukkanen, et al. HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS 1998;12:1907-19.
26. Luo CC, Tian C, Hu DJ, Kai M, Dondero TJ, Zheng X. HIV-1 subtype C in China. Lancet 1995;345:1051-2.
27. Ou CY, Takebe Y, Weniger BG, et al. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet 1993;341:1171-4.
28. Grez M, Dietrich U, Balfe P, et al. Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread a HIV-1 and HIV-2 from a single ancestor for each of these viruses. J Viral 1994;68:2161-8.
29. Hahn BH, Robertson DL, Sharp PM. Intersubtype recombination in HIV-1 and HIV-2, pIII-22-III-29. In: Myers G, Korber B, Wain-Hobson S, Jeang K-T, Henderson LE, Pavlakis GN, eds. Human retroviruses and AIDs 1995: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos, NM: Los Alamos National Laboratory: Theoretical Biology and Biophysics, 1995.
30. Delwart EL, Shpaer EG, McCutchan FE, et al. Genetic relationships determined by a heteroduplex mobility assay: analysis of HIV env genes. Science 1993;262:1257-61.
31. Delwart EL, Sheppard HW, Walker BD, Goudsmit J, Mullins JI. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virol 1994;68:6672-83.
32. Mc Keating JA. Biological consequences of human immunodeficiency virus type 1 envelope polymorphism: does variation matter? J Gen Virol 1996;77:2905-19.
33. Barin F, Lahbabi Y, Buzelay L, et al. Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping. AIDS Res Hum Retroviruses 1996;12:1279-89.
34. Cheingsong-Popov R, Lister S, Callow D, et al. Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. AIDS Res Hum Retroviruses 1994;11:1379-86.
35. Pau CP, Kai M, Holloman-Candal DL, et al. Antigenic variation and serotyping of HIV type 1 from four World Health Organisation-sponsored HIV vaccine sites. AIDS Res Hum Retroviruses 1994;11:1369-77.
36. Smith JD, Bruce CB, Featherstone ASR, et al. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1994; 10:577-83.
37. Zwart G, Wolf TFW, Bookelman R, et al. Greater diversity of the HIV-1 V3 neutralization domain in Tanzania compared with the Netherlands: serological and genetic analysis. AIDS 1993;7:467-74.
38. Plantier JC, Le Pogam S, Poisson F, Lejeune B, Barin F. Extent of antigenic diversity in the V3 region of the surface glycoprotein, gp120, of human immunodeficiency virus type 1 (HIV-1) group M and consequences for serotyping. J Virol 1998;72:677-83.
39. Merrifield RB. Solid-phase peptide synthesis I. The synthesis of a tetrapeptide. J Am Chem Soc 1963;85:2149-54.
40. Apetrei C, Loussert-Ajaka I, Collin G, et al. HIV type 1 subtype F sequences in Romanian children and adults. AIDS Res Hum Retroviruses 1997;13:363-5.
41. Lasky M, Perret JL, Peeters M, et al. Presence of multiple non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment. AIDS 1997;11:43-51.
42. Marlink R, Kanki P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994; 265:1587-90.
43. Wolinsky SM, Wike CM, Korber BT, et al. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992;255:1134-7.
44. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-80.
45. Sherefa K, Sönnerborg A, Steinbergs J, Sâllberg M. Rapid grouping of HIV-1 infection in subtypes A to E by V3 peptide serotyping and its relation to sequence analysis. Biochem Biophys Res Commun 1994;205:1658-64.
46. Gorny MK, Xu JY, Gianakakos V, et al. Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein. Proc Natl Acad Sci USA 1991;88:3238-42.
47. Gorny MK, Conley AJ, Karwoswka S, et al. Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J Virol 1992;66:7538-42.
48. Cheingsong-Popov R, Osmanov S, Pau CP, et al. Serotyping of HIV-1 infections: definition, classification, relationship to viral genetic subtypes and assay evaluation. AIDS Res Hum Retroviruses 1998;14:311-8.
49. Hoelscher M, Hanker S, Barin F, et al. Evaluation of four different V3 loop peptide ELISAs for HIV-1 serotyping in an East African region; a feasible tool for molecular epidemiology? AIDS Res Hum Retroviruses 1998;14:139-49.
50. Gaywee J, Artenstein AW, VanCott TC, et al. Correlation of genetic and serologic approaches to HIV-1 subtyping in Thailand. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:392-6.
51. Wasi C, Herring B, Raktham S, et al. Determination of HIV-1 subtypes in injecting drugs users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and heteroduplex mobility assay: evidence of increasing infection with HIV-1 subtype E. AIDS 1995;9:843-9.
52. M serotypes in French blood donors over a 10-year period (1985-1995). AIDS 1997;11:1503-8.
53. Desgranges C, Fillon S, Audoly G, et al. Presence of HIV-1 subtypes B and F and HTLV-I in HIV/HTLV coinfected individuals of Martinique. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:468-70.
54. Korber BTM, McInnes K, Smith RF, Myers G. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J Virol 1994;68:6730-44.
55. Rini JM, Stanfield RL, Stura EA, Salinas PA, Profy AT, Wilson IA. Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. Proc Natl Acad Sci USA 1993;90:6325-9.
56. Ratner L, Haseltine W, Patarca R, et al. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 1985;313:277-84.